ELAC2 and cardiac hypertrophy: In humans, multiple mutations of ELAC2 have been associated with the early onset of cardiac hypertrophy and decompensation (Haack et al., 2013; Shinwari et al., 2017), although the causal connection between mutant ELAC2 forms and CM has not been explicitly established.